Development of an Injectable Synergistically Crosslinked Polysaccharide Hydrogel with Antioxidant and Antibacterial Properties for Promoting Wound Healing
Sign Up to like & getrecommendations! Published in 2025 at "Macromolecular Bioscience"
DOI: 10.1002/mabi.202500084
Abstract: The development of wound dressings that concurrently exhibit excellent injectability, antibacterial performance, and tissue adhesion is essential for the effective treatment of hard‐to‐heal wounds. Polysaccharide‐based hydrogels have become a research hotspot due to their favorable… read more here.
Keywords: development injectable; injectable synergistically; hydrogel; wound healing ... See more keywords
Development of an Injectable, ECM-Derivative Embolic for the Treatment of Cerebral Saccular Aneurysms
Sign Up to like & getrecommendations! Published in 2024 at "Biomacromolecules"
DOI: 10.1021/acs.biomac.4c00321
Abstract: Cerebral aneurysms are a source of neurological morbidity and mortality, most often as a result of rupture. The most common approach for treating aneurysms involves endovascular embolization using nonbiodegradable medical devices, such as platinum coils.… read more here.
Keywords: development injectable; derivative embolic; embolic treatment; cellular infiltration ... See more keywords
Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics
Sign Up to like & getrecommendations! Published in 2018 at "mAbs"
DOI: 10.1080/19420862.2017.1392424
Abstract: ABSTRACT The development of an injectable drug-device combination (DDC) product for biologics is an intricate and evolving process that requires substantial investments of time and money. Consequently, the commercial dosage form(s) or presentation(s) are often… read more here.
Keywords: injectable drug; drug device; strategy; development ... See more keywords